Immunology
print


Breadcrumb Navigation


Content

Publications

Bargou R, Leo E, Zugmaier G, Klinger M, Goebeler M, Knop S, Noppeney R, Viardot A, Hess G, Schuler M, Einsele H, Brandl C, Wolf A, Kirchinger P, Klappers P, Schmidt M, Riethmüller G, Reinhardt C, Baeuerle PA, Kufer P.
Tumor regression in cancer patients by very low doses of a T cell-engaging antibody.
Science. 2008 Aug 15;321(5891):974-7.

Hüsemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmüller G, Klein CA.Systemic spread is an early step in breast cancer.Cancer Cell. 2008 Jan;13(1):58-68

Mecklenburg I, Weckermann D, Zippelius A, Schoberth A, Petersen S, Prang N, Riethmüller G, Kufer P.A multimarker real-time RT-PCR for MAGE-A gene expression allows sensitive detection and quantification of the minimal systemic tumor load in patients with localized cancer.J Immunol Methods. 2007 Jun 30;323(2):180-93. Epub 2007 May 15

Schreiber K, Rowley DA, Riethmüller G, Schreiber H.AbstractCancer immunotherapy and preclinical studies: why we are not wasting our time with animal experiments.Hematol Oncol Clin North Am. 2006 Jun;20(3):567-84. Review

Mack M, Pfirstinger J, Haas J, Nelson PJ, Kufer P, Riethmüller G, Schlöndorff D.Preferential targeting of CD4-CCR5 complexes with bifunctional inhibitors: a novel approach to block HIV-1 infection.J Immunol. 2005 Dec 1;175(11):7586-93

Mecklenburg I, Stratakis DF, Huber RM, Häussinger K, Morresi-Hauf A, Riethmüller G, Kufer P.Detection of melanoma antigen-A expression in sputum and bronchial lavage fluid of patients with lung cancer.Chest. 2004 May;125(5 Suppl):164S-6S. No abstract available

Ulmer A, Schmidt-Kittler O, Fischer J, Ellwanger U, Rassner G, Riethmüller G, Fierlbeck G, Klein CA.Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells.Clin Cancer Res. 2004 Jan 15;10(2):531-7.

Mocikat R, Braumüller H, Gumy A, Egeter O, Ziegler H, Reusch U, Bubeck A, Louis J, Mailhammer R, Riethmüller G, Koszinowski U, Röcken M.Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses.Immunity. 2003 Oct;19(4):561-9.

Schmidt-Kittler O, Ragg T, Daskalakis A, Granzow M, Ahr A, Blankenstein TJ, Kaufmann M, Diebold J, Arnholdt H, Muller P, Bischoff J, Harich D, Schlimok G, Riethmuller G, Eils R, Klein CA.From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression.Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7737-42. Epub 2003 Jun 13.

Kufer P, Zettl F, Borschert K, Lutterbüse R, Kischel R, Riethmüller G.Minimal costimulatory requirements for T cell priming and TH1 differentiation: activation of naive human T lymphocytes by tumor cells armed with bifunctional antibody constructs.Cancer Immun. 2001 Nov 12;1:10

Schadendorf D, Dorn-Beineke A, Borelli S, Riethmuller G, Pantel K.Limitations of the immunocytochemical detection of isolated tumor cells in frozen samples of bone marrow obtained from melanoma patients.Exp Dermatol. 2003 Apr;12(2):165-71.

More publications available at PubMed


Service